Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 12, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share acquisitions under the Company's ShareReward Plan ("the Plan") on January 11, 2006. The transactions involved the purchase of Ordinary Shares at a price of GBP 14.79 per share. The following individuals acquired shares:
- Mr J S Heslop: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
- Mr R Bondy: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
- Mr A P Witty: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
- Mrs J V Younger: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the share price of GBP 14.79 against market data for January 11, 2006.
- Confirm the terms of the ShareReward Plan entered into on October 5, 2001, regarding the matching element.
- Check subsequent filings for any further changes in director shareholdings.